270 related articles for article (PubMed ID: 667861)
1. Clinical spectrum of anthracycline antibiotic cardiotoxicity.
Bristow MR; Billingham ME; Mason JW; Daniels JR
Cancer Treat Rep; 1978 Jun; 62(6):873-9. PubMed ID: 667861
[TBL] [Abstract][Full Text] [Related]
2. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
3. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
Jensen BV
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
[TBL] [Abstract][Full Text] [Related]
4. Clinical and non-invasive assessment of anthracycline cardiotoxicity: perspectives on myocardial protection.
Mortensen SA; Aabo K; Jonsson T; Baandrup U
Int J Clin Pharmacol Res; 1986; 6(2):137-50. PubMed ID: 3459718
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of cardiotoxicity induced by anthracyclines.
Elliott P
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283
[TBL] [Abstract][Full Text] [Related]
6. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.
Hequet O; Le QH; Moullet I; Pauli E; Salles G; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Antal D; Bouafia F; Coiffier B
J Clin Oncol; 2004 May; 22(10):1864-71. PubMed ID: 15143078
[TBL] [Abstract][Full Text] [Related]
7. [Biventricular heart failure in patient treated with anthracycline in childhood: myocardial dysfunction is not always the cause].
Iarussi D; Martino V; Iacono C; Indolfi P; Muto R; Calabrò R
Ital Heart J Suppl; 2004 Apr; 5(4):294-7. PubMed ID: 15185468
[TBL] [Abstract][Full Text] [Related]
8. Time- and dose-dependent changes in ejection fraction determined by radionuclide angiography after anthracycline therapy.
Singer JW; Narahara KA; Ritchie JL; Hamilton GW; Kennedy JW
Cancer Treat Rep; 1978 Jun; 62(6):945-8. PubMed ID: 667873
[TBL] [Abstract][Full Text] [Related]
9. [Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology].
Biron P; Philip T; Bouffet E; Favrot MC; Pinkerton R; Brunat-Mentigny M
Pathol Biol (Paris); 1987 Jan; 35(1):97-101. PubMed ID: 3550619
[TBL] [Abstract][Full Text] [Related]
10. [Cardiotoxicity of anthracyclines].
Ferrière M; Donadio D; Ramirez R
Arch Mal Coeur Vaiss; 1993 Feb; 86 Spec No 2():53-8. PubMed ID: 8215791
[TBL] [Abstract][Full Text] [Related]
11. Anthracycline cardiotoxicity in long-term survivors of childhood cancer.
Scully RE; Lipshultz SE
Cardiovasc Toxicol; 2007; 7(2):122-8. PubMed ID: 17652816
[TBL] [Abstract][Full Text] [Related]
12. Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents.
Chen C; Heusch A; Donner B; Janssen G; Göbel U; Schmidt KG
Klin Padiatr; 2009; 221(3):162-6. PubMed ID: 19437364
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA
Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095
[TBL] [Abstract][Full Text] [Related]
14. [Cardiotoxicity of anthracyclines. Apropos of 12 pediatric cases].
Favrot MC; Pouyau G; Souillet G; Philip T; Bozzio A; Philippe N
Pediatrie; 1981 Sep; 36(6):437-50. PubMed ID: 6947199
[No Abstract] [Full Text] [Related]
15. Overview of cardiac pathology in relation to anthracycline cardiotoxicity.
Ferrans VJ
Cancer Treat Rep; 1978 Jun; 62(6):955-61. PubMed ID: 352510
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy and cardiotoxicity].
Brestescher C; Pautier P; Farge D
Ann Cardiol Angeiol (Paris); 1995 Oct; 44(8):443-7. PubMed ID: 8669796
[TBL] [Abstract][Full Text] [Related]
17. Role of mtDNA lesions in anthracycline cardiotoxicity.
Lebrecht D; Walker UA
Cardiovasc Toxicol; 2007; 7(2):108-13. PubMed ID: 17652814
[TBL] [Abstract][Full Text] [Related]
18. Serum carnitine levels during the doxorubicin therapy. Its role in cardiotoxicity.
Yaris N; Ceviz N; Coskun T; Akytüz C; Büyükpamukçu M
J Exp Clin Cancer Res; 2002 Jun; 21(2):165-70. PubMed ID: 12148572
[TBL] [Abstract][Full Text] [Related]
19. Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients.
Hutchinson RJ; Bailey C; Wood D; Donaldson MH
Cancer Treat Rep; 1978 Jun; 62(6):907-10. PubMed ID: 667866
[TBL] [Abstract][Full Text] [Related]
20. [Heart failure in a subject treated with anthracyclines in childhood: myocardial dysfunction is not always the only reason of it].
Iarussi D; Martino V; Iacono C; Indolfi P; Muto R; Calabrò R
Ital Heart J Suppl; 2004 Apr; 5(4):294-7. PubMed ID: 15346697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
